substanti
find
focus
respiratori
virus
frequent
pathogen
besid
viral
outbreak
nicu
report
indic
signific
impact
health
outcom
cost
emerg
new
detect
method
multiplex
revers
transcriptionpolymeras
chain
reaction
enzymelink
immunosorb
assay
multiplex
rtpcr
elisa
tremend
facilit
detect
virus
multiplex
rtpcr
elisa
allow
screen
larg
number
differ
virus
singl
specimen
first
evid
viral
infect
term
preterm
neonat
birth
hospit
signific
impact
shortand
longterm
morbid
preced
feasibl
studi
demonstr
techniqu
use
detect
respiratori
virus
case
clinic
deterior
nicu
aim
present
studi
elucid
occurr
viral
infect
neonat
suspect
lateonset
sepsi
perform
singlecent
studi
nicu
univers
medic
center
johann
gutenberg
univers
mainz
level
iii
unit
intens
care
cot
alloc
three
room
two
room
five
four
cot
singl
room
unit
usual
admit
patient
deliveri
room
postnat
ward
locat
nearbi
build
previous
discharg
patient
patient
special
care
unit
readmit
except
case
unit
open
visitor
due
limit
space
number
simultan
visitor
restrict
two
per
patient
parent
visitor
instruct
proper
hand
hygien
repeatedli
ask
wear
facemask
case
sign
minor
respiratori
tract
infect
sibl
age
may
visit
nicu
clinic
examin
verifi
sign
infect
prospect
cohort
studi
conduct
august
march
local
ethic
committe
approv
studi
parent
approach
inform
consent
admiss
infant
elig
studi
hour
onward
admiss
whether
follow
birth
later
life
infant
intraven
antibiot
treatment
initi
due
suspect
lateonset
bacteri
sepsi
enrol
consecut
enrol
infant
could
test
repeatedli
event
independ
episod
suspect
sepsi
decis
start
intraven
antibiot
clinician
discret
blood
cultur
sampl
mandatori
prior
start
antibiot
one
posit
blood
cultur
consid
suffici
diagnos
bacteri
bloodstream
infect
also
case
coagulaseneg
staphylococci
enrol
infant
test
respiratori
gastrointestin
virus
within
next
hour
nasopharyng
aspir
npa
analyz
use
inhous
multiplex
rtpcr
elisa
describ
previous
assay
includ
adenoviru
respiratori
syncyti
viru
rsv
influenza
viru
b
viru
parainfluenza
viru
metapneumoviru
coronaviru
picornaviru
stool
sampl
test
rotaviru
adenoviru
noroviru
use
commerci
avail
antigen
test
ridascreen
rbiopharm
darmstadt
germani
enteroviru
via
inhous
pcr
local
institut
virolog
case
posit
antigen
test
confirm
test
use
pcr
perform
sampl
viru
detect
via
pcr
consid
posit
result
infant
clinic
demograph
characterist
laboratori
marker
clinic
present
immedi
document
written
case
report
form
follow
pseudonym
studi
personnel
transfer
data
prespecifi
microsoft
excel
databas
microsoft
offic
version
save
data
infant
pathogen
detect
addit
check
correct
complet
correspond
author
use
origin
patient
file
result
viral
test
blind
clinician
unit
case
posit
test
infant
isol
hospit
cohort
whenev
possibl
avoid
feel
guilt
especi
affect
parent
resign
idea
screen
close
contact
intent
studi
period
infant
admit
nicu
parent
given
inform
consent
enrol
case
total
infant
elig
enrol
studi
infant
exclud
due
incomplet
nonanalyz
sampl
final
patient
sepsi
episod
analyz
analysi
includ
sepsi
episod
report
feasibl
studi
clinic
demograph
data
enrol
case
present
sever
infant
experienc
multipl
episod
suspect
lateonset
sepsi
total
infant
underw
one
infant
two
infant
three
sepsi
evalu
episod
suspect
lateonset
bacteri
sepsi
neither
bacteri
viral
pathogen
detect
posit
respiratori
viru
test
observ
six
infant
rsv
detect
two
picornaviru
four
infant
one
infant
three
anoth
infant
two
consecut
episod
posit
pcr
result
picornaviru
episod
identifi
new
clinic
deterior
infant
recov
antibiot
stop
episod
viral
test
perform
asymptomat
interv
two
infant
rsv
infect
yet
receiv
rsv
immun
characterist
virusposit
infant
summar
viru
posit
blood
cultur
never
detect
simultan
howev
one
infant
diagnos
viral
infect
picornaviru
day
postnat
later
cours
proven
bacteri
bloodstream
infect
klebsiella
oxytoca
day
postnat
respiratori
viral
infect
occur
cluster
nicu
none
virusposit
infant
discharg
home
previous
stool
examin
show
two
posit
antigen
test
adenoviru
one
posit
test
noroviru
retest
via
pcr
none
three
posit
antigen
test
could
confirm
enteroviru
rotaviru
detect
studi
infant
studi
period
vaccin
rotaviru
perform
characterist
infant
blood
cultureproven
sepsi
present
studi
period
fungal
bloodstream
infect
diagnos
viru
detect
nicu
import
issu
consid
contribut
success
antibiot
stewardship
provid
specif
valid
algorithm
implement
clinic
routin
although
evid
still
lack
use
multiplex
rtpcr
elisa
detect
respiratori
virus
provid
medic
econom
benefit
neonat
pediatr
patient
potenti
benefit
viru
detect
may
aris
earli
implement
effect
isol
infect
control
measur
prevent
viral
spread
particular
import
sinc
modern
familycent
neonat
care
includ
kangaroo
care
unit
alway
open
parent
sibl
bear
increas
risk
viru
transmiss
studi
viral
infect
alway
present
respiratori
symptom
albeit
clinic
characterist
highli
heterogen
compar
bacteri
infect
nosocomi
viral
infect
occur
rather
late
birth
hospit
unclear
whether
due
physiolog
factor
decreas
matern
passiv
immun
simpli
due
longterm
hospit
affect
infant
either
extrem
prematur
infant
term
infant
pulmonari
thorac
diseas
present
respiratori
distress
might
patient
high
risk
viral
test
definit
consid
case
suspect
lateonset
sepsi
multiplex
rtpcr
elisa
nasopharyng
specimen
previous
use
detect
respiratori
virus
nicu
result
similar
recent
publish
ronchi
et
al
studi
compar
design
includ
similar
number
infant
compar
incid
viral
respiratori
infect
case
sepsi
evalu
nicu
observ
likewis
rhinoviru
member
picornaviru
famili
domin
pathogen
bennett
et
al
perform
surveil
studi
viral
respiratori
infect
two
nicu
infant
gestat
age
week
test
twice
week
use
multiplex
rtpcr
elisa
author
found
test
infant
posit
viru
screen
least
birth
hospit
contrast
studi
identifi
infant
posit
viru
screen
minim
clinic
symptom
anoth
studi
gonzalezcarrasco
et
al
use
mix
design
weekli
surveil
addit
test
event
respiratori
symptom
studi
sampl
posit
total
infant
affect
symptomat
rhinoviru
frequent
found
case
doubt
whether
detect
viru
npa
realli
prove
activ
respiratori
viral
infect
contrast
previou
studi
suggest
picornavirusesrhinovirus
major
caus
pathogen
infant
lower
respiratori
tract
infect
rhinoviru
may
detect
week
follow
infect
shorter
clearanc
around
week
also
describ
sinc
activ
shed
clearanc
occur
repeat
detect
rhinoviru
may
rather
reflect
resolv
subclin
upper
respiratori
tract
infect
colon
remain
unclear
result
appli
preterm
infant
birth
hospit
largescal
futur
studi
screen
cohort
asymptomat
infant
serial
quantit
pcr
analys
might
help
evalu
whether
clinic
deterior
may
caus
reactiv
persist
subclin
viral
infect
allow
discrimin
harmless
colon
true
infect
futur
studi
would
ideal
consist
three
cohort
asymptomat
viru
neg
asymptomat
viru
posit
symptomat
viru
posit
addit
implement
hostbas
rtpcr
gene
express
assay
clinic
practic
might
offer
significantli
improv
tool
diagnos
viral
infect
furthermor
rang
virus
screen
expand
quit
recent
studi
compar
design
investig
human
parechoviru
blood
sampl
case
suspect
lateonset
sepsi
nicu
found
high
infect
rate
research
also
focu
mode
viru
transmiss
patient
risk
impact
prevent
measur
longterm
outcom
viral
infect
birth
hospit
main
result
present
studi
oral
present
intern
confer
clinic
neonatolog
torino
itali
septemb
fund
none
